Results 101 to 110 of about 52,108 (298)
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.
Managing Acquired TTP without Plasma Exchange A case of acquired thrombotic thrombocytopenic purpura is reported in a Jehovah’s Witness who had neurologic manifestations but would not accept plasma...
Deepak P. Chander+3 more
semanticscholar +1 more source
ABSTRACT Target‐mediated drug disposition (TMDD) is often associated with high‐affinity binding to a target resulting in nonlinear pharmacokinetics. For large molecules, such as monoclonal antibodies, this can lead to increased clearance at sub‐saturating concentrations.
Ronny Straube
wiley +1 more source
Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura. [PDF]
INTRODUCTION: Genetic and autoimmune risk factors contribute to the development of thrombotic thrombocytopenic purpura (TTP) but triggers are needed to bring about acute disease.
Brill+44 more
core +1 more source
Introduction Since the first description of Thrombotic Thrombocytopenic Purpura, caused by a severe deficiency of ADAMTS13, plasma exchange and immunosuppression have become standard treatments, allowing to decrease its high mortality rate.
Daniel Cathalifaud+6 more
doaj +1 more source
Abstract Introduction It remains to be established whether it provides any clinical or diagnostic benefits to perform ventilation/perfusion (V/Q) scintigraphy as a single photon emission computed tomography in children. Here, we report our experience with this modality, evaluate its impact on clinical decision‐making and assess its interrater agreement.
Lise Borgwardt+6 more
wiley +1 more source
Rituximab induced pulmonary edema managed with extracorporeal life support [PDF]
Though rare, rituximab has been reported to induce severe pulmonary edema. We describe the first report of ECLS utilization for this indication. A 31-year-old female with severe thrombotic thrombocytopenic purpura developed florid pulmonary edema after ...
Aguilar, Patrick+6 more
core +3 more sources
Complete Recovery of Ischemic Cardiomyopathy from Thrombotic Thrombocytopenic purpura
A 50 year old male HIV patient on antiretroviral therapy was admitted for chest pain. Upon admission, the patient was found to have elevated cardiac enzymes, acute thrombocytopenia, hemolytic anemia, acute pancreatitis and acute renal failure.
Sainath Gaddam+7 more
doaj +1 more source
Severe Acral Necrosis Complicating Thrombotic Microangiopathy in Two Toddlers
Acral ischemia/necrosis is one of the rarest but most dreadful complications of thrombotic microangiopathy in pediatric patients. It is more reported with thrombotic thrombocytopenic purpura than with hemolytic and uremic syndrome.
H. Nassih, Z. Lazrak, S. Younous
doaj +1 more source
ABSTRACT Introduction Inherited coagulation factor deficiencies (ICFD) result from plasma protein deficiencies, impacting blood coagulation cascade and leading to haemorrhagic diathesis. Advancements in next‐generation sequencing (NGS) technology have enabled high‐throughput methods for molecular ICFD diagnosis.
Nina Borràs+17 more
wiley +1 more source
Thrombotic Thrombocytopenic Purpura [PDF]
In 1924 Moschcowitz reported the case of a patient who died following a brief illness characterized by fever, haernolytic anaemia, a bleeding tendency, and terminal neurological signs. Histological examination revealed widespread hyaline thromboses in the capillaries and terminal arterioles, Baehr et al.
O. C. Lloyd, D. J. Ellison
openaire +2 more sources